155 related articles for article (PubMed ID: 12109940)
1. Plasma adsorption in critical care.
Yang KS; Kenpe K; Yamaji K; Tsuda H; Hashimoto H
Ther Apher; 2002 Jun; 6(3):184-8. PubMed ID: 12109940
[TBL] [Abstract][Full Text] [Related]
2. Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome.
Okamiya S; Ogino M; Ogino Y; Irie S; Kanazawa N; Saito T; Sakai F
Ther Apher Dial; 2004 Jun; 8(3):248-53. PubMed ID: 15154879
[TBL] [Abstract][Full Text] [Related]
3. Double-filtration plasmapheresis.
Tanabe K
Transplantation; 2007 Dec; 84(12 Suppl):S30-2. PubMed ID: 18162985
[TBL] [Abstract][Full Text] [Related]
4. Plasma exchange versus double filtration plasmapheresis in the treatment of Guillain-Barré syndrome.
Lyu RK; Chen WH; Hsieh ST
Ther Apher; 2002 Apr; 6(2):163-6. PubMed ID: 11982959
[TBL] [Abstract][Full Text] [Related]
5. Plasma immunoadsorption therapy for Guillain-Barré syndrome: critical day for initiation.
Takei H; Komaba Y; Araki T; Iino Y; Katayama Y
J Nippon Med Sch; 2002 Dec; 69(6):557-63. PubMed ID: 12646988
[TBL] [Abstract][Full Text] [Related]
6. [Apheresis therapy in Guillain-Barré syndrome].
Nagayama H; Katayama Y
Nihon Rinsho; 2008 Jun; 66(6):1195-9. PubMed ID: 18540370
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of clinical effects between plasma adsorption and double filtration plasmapheresis in patients with myasthenia gravis.
Okada H; Moriwaki K; Sugahara S; Nakamoto H; Hosokawa T; Hamaguchi K; Suzuki H
Ther Apher; 1997 Nov; 1(4):343-7. PubMed ID: 10225728
[TBL] [Abstract][Full Text] [Related]
8. Ability to remove immunoglobulins and anti-ganglioside antibodies by plasma exchange, double-filtration plasmapheresis and immunoadsorption.
Tagawa Y; Yuki N; Hirata K
J Neurol Sci; 1998 Apr; 157(1):90-5. PubMed ID: 9600682
[TBL] [Abstract][Full Text] [Related]
9. Isoagglutinin removal by plasma centrifugation or filtration (single or double): A prospective study in a single center.
Naciri Bennani H; Noble J; Chevallier E; Terrec F; Motte L; Giroux-Lathuile C; Bugnazet M; Imerzoukene F; Janbon B; Malvezzi P; Rostaing L; Jouve T
J Clin Apher; 2021 Feb; 36(1):149-160. PubMed ID: 33230824
[TBL] [Abstract][Full Text] [Related]
10. Successful ABO incompatible renal transplantation following rituximab and DFPP after failed immunoadsorption.
Thalgahagoda S; Webb NJ; Roberts D; Birch A; Milford DV; Tavakoli A; Shenoy M
Pediatr Transplant; 2014 May; 18(3):E74-6. PubMed ID: 24483150
[TBL] [Abstract][Full Text] [Related]
11. [Plasmapheresis in patients with myasthenia gravis].
Konishi T
Nihon Rinsho; 2008 Jun; 66(6):1165-71. PubMed ID: 18540364
[TBL] [Abstract][Full Text] [Related]
12. Double filtration plasmapheresis in critical care.
Mineshima M; Akiba T
Ther Apher; 2002 Jun; 6(3):180-3. PubMed ID: 12109939
[TBL] [Abstract][Full Text] [Related]
13. Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late-onset myasthenia gravis.
Liu JF; Wang WX; Xue J; Zhao CB; You HZ; Lu JH; Gu Y
Ther Apher Dial; 2010 Apr; 14(2):153-60. PubMed ID: 20438536
[TBL] [Abstract][Full Text] [Related]
14. Double filtration plasmapheresis in antibody-incompatible kidney transplantation.
Higgins R; Lowe D; Hathaway M; Lam FT; Kashi H; Tan LC; Imray C; Fletcher S; Chen K; Krishnan N; Hamer R; Zehnder D; Briggs D
Ther Apher Dial; 2010 Aug; 14(4):392-9. PubMed ID: 20649760
[TBL] [Abstract][Full Text] [Related]
15. Can immunoadsorption plasmapheresis be used as the first choice therapy for neuroimmunological disorders?
Yamawaki T; Suzuki N
Ther Apher; 1997 Nov; 1(4):348-52. PubMed ID: 10225729
[TBL] [Abstract][Full Text] [Related]
16. Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis.
Sawada T; Fuchinoue S; Teraoka S
Transplantation; 2002 Nov; 74(9):1207-10. PubMed ID: 12451255
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of immunoadsorption and double filtration plasmapheresis for removal of anti-A or -B antibody in ABO-incompatible kidney transplantation. Japanese Biosynsorb Research Group.
Agishi T; Takahashi K; Ota K; Yagisawa T
Transplant Proc; 1992 Apr; 24(2):557-8. PubMed ID: 1566429
[No Abstract] [Full Text] [Related]
18. Experience of double filtration plasmapheresis in the treatment of Guillain-Barré syndrome.
Chen WH; Yeh JH; Chiu HC
J Clin Apher; 1999; 14(3):126-9. PubMed ID: 10540367
[TBL] [Abstract][Full Text] [Related]
19. Immunoadsorption in Guillain-Barré syndrome and myasthenia gravis.
Haupt WF; Rosenow F; van der Ven C; Birkmann C
Ther Apher; 2000 Jun; 4(3):195-7. PubMed ID: 10910018
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of theefficacy of removal of anti-ABO and anti-gal antibodies by double filtration plasmapheresis.
Kobayashi T; Yokoyama I; Morozumi K; Nagasaka T; Hayashi S; Uchida K; Takagi H; Nakao A
Xenotransplantation; 2000 May; 7(2):101-8. PubMed ID: 10961294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
